HiFiBiO Therapeutics

An emerging clinical stage multinational company mobilizing the human immune system to treat cancer and autoimmune diseases.

HQ location

Cambridge, United States

Founding location

Paris, France

Website

Launch date

2013

Employees

Enterprise value

$300—450m

Company register number

794660209

Recent deals

H-Immune

https://twitter.com/hifibio https://www.linkedin.com/company/hifibiotherapeutics/hifibio

Authorizing premium user...